NAVB
Navidea Biopharmaceuticals Inc.
NAVB
NAVB
Delisted
NAVB was delisted on the 5th of October, 2023.
74 hedge funds and large institutions have $46.7M invested in Navidea Biopharmaceuticals Inc. in 2016 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 17 increasing their positions, 20 reducing their positions, and 12 closing their positions.
Holders
74
Holders Change
-4
Holders Change %
-5.13%
% of All Funds
1.97%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
8
Increased
17
Reduced
20
Closed
12
Calls
$65K
Puts
$85K
Net Calls
-$20K
Net Calls Change
+$7.97M
Top Buyers
| 1 |
PM
1
Platinum Management
New York
|
$14.7M |
| 2 |
2
D.E. Shaw & Co
New York
|
$191K |
| 3 |
3
SG Americas Securities
New York
|
$92K |
| 4 |
4
Citigroup
New York
|
$122K |
| 5 |
RFC
5
Russell Frank Company
Seattle,
Washington
|
$67K |
